COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis (Phase2b)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03538951
Recruitment Status : Unknown
Verified May 2018 by Vidac Pharma.
Recruitment status was:  Recruiting
First Posted : May 29, 2018
Last Update Posted : May 30, 2018
Therapeutics, Inc.
PharPoint Research, Inc.
Medistat Ltd., Israel
Information provided by (Responsible Party):
Vidac Pharma

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 15, 2019
Estimated Study Completion Date : January 15, 2019